Avalo Therapeutics, Inc. · NASDAQ:AVTX

Caligan Partners LP reported a 7.20% stake in Avalo Therapeutics, Inc. (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 15, 2026

Caligan Partners LP reported a 7.20% stake in Avalo Therapeutics, Inc., 1,635,023 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).

Stake
7.20%
Shares
1,635,023
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Caligan Partners LP7.20%1,635,023
David Johnson7.20%1,635,023

Source

View original at SEC

Related